Over a month ago |
Recommendations
|
Cowen analyst Ashwin… Cowen analyst Ashwin Shirvaikar raised the firm's price target on Accenture to $300 from $295 and keeps an Outperform rating on the shares. The analyst said near-term caution on growth and margin yields a second half ramp that may be hard to underwrite as 2023 enterprise IT budgets await finalization. However, the company's growth trajectory and diversification at unmatched scale remains attractive as a relative shelter vs. tech services alternatives. ShowHide Related Items >><< - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 12/19/22 Jefferies
- Accenture price target lowered to $279 from $290 at Jefferies
- 12/19/22 Cowen
- Accenture price target raised to $300 from $295 at Cowen
- 12/19/22 Baird
- Accenture price target lowered to $290 from $310
- 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 12/05/22
- Allstate replacing Accenture's Droga5 for creative account, AdAge reports
- 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/16/22
- Fly Intel: Pre-market Movers
- 12/12/22
- What You Missed On Wall Street On Monday
|
Recommendations
|
Jefferies analyst… Jefferies analyst Surinder Thind lowered the firm's price target on Accenture to $279 from $290 and keeps a Hold rating on the shares, telling investors that he is "slightly more cautious" following the company's fiscal Q1 earnings report. The reiteration of FY23 constant currency revenue growth is "an important positive," as it suggests there has not been a meaningful shift in overall client demand since last quarter, said Thind, who adds that the guidance "should be viewed with some caution" with clients yet to finalize 2023 budgets. ShowHide Related Items >><< - $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- $264.42 /
-16.66 (-5.93%) - 12/19/22 Cowen
- Accenture price target raised to $300 from $295 at Cowen
- 12/19/22 Baird
- Accenture price target lowered to $290 from $310
- 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- $264.42 /
-16.66 (-5.93%) - 12/05/22
- Allstate replacing Accenture's Droga5 for creative account, AdAge reports
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/16/22
- Fly Intel: Pre-market Movers
- 12/12/22
- What You Missed On Wall Street On Monday
|
Recommendations
|
Cowen analyst Ashwin… Cowen analyst Ashwin Shirvaikar raised the firm's price target on Accenture to $300 from $295 and keeps an Outperform rating on the shares. The analyst said its lower revenue growth guidance captures incremental client prudence amid macro uncertainty, offsetting a solid 1Q. ShowHide Related Items >><< - $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- $264.42 /
-16.66 (-5.93%) - 12/19/22 Baird
- Accenture price target lowered to $290 from $310
- 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- $264.42 /
-16.66 (-5.93%) - 12/05/22
- Allstate replacing Accenture's Droga5 for creative account, AdAge reports
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/16/22
- Fly Intel: Pre-market Movers
- 12/12/22
- What You Missed On Wall Street On Monday
|
Recommendations
|
Baird analyst David… Baird analyst David Koning lowered the firm's price target on Accenture to $290 from $310 and keeps a Neutral rating on the shares. The analyst said Q1 results were solid, but Bookings decelerated to +6% year-over-year and Consulting Book-to-Bill was less than1X. Koning views the risk/reward as balanced but interesting around $250. ShowHide Related Items >><< - $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- $264.42 /
-16.66 (-5.93%) - 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- $264.42 /
-16.66 (-5.93%) - 12/05/22
- Allstate replacing Accenture's Droga5 for creative account, AdAge reports
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- What You Missed On Wall Street On Friday
- 12/16/22
- What You Missed On Wall Street This Morning
- 12/16/22
- Fly Intel: Pre-market Movers
- 12/12/22
- What You Missed On Wall Street On Monday
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/15/22
- Trane commits to low-carbon steel purchases from Nucor, U.S. Steel
- 11/08/22
- U.S. Steel announces tentative agreement with United Steelworkers
- 09/15/22
- U.S. Steel slips after Q3 earnings guidance
- 08/16/22
- U.S. Steel, Equinor and Shell enter a cooperation agreement for clean energy hub
- 12/16/22
- Winnebago CEO says 2023 'critically important' for maintaining momentum
- 11/15/22
- Winnebago presents 2025 targets at investor day
- 11/15/22
- Winnebago to establish dedicated research, development facility
- 10/19/22
- Winnebago falls -10.4%
WBD Warner Bros. Discovery - 12/14/22
- Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023
- 12/06/22
- Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S.
- 11/14/22
- U.S. game content spending grew 2% y/y in October, says NPD
- 11/10/22
- Sony says 'Modern Warfare II' tops PS5 digital downloads in October
- 11/25/22
- Travelzoo to sell 3.41M shares to largest shareholder, Azzurro Capital
- 10/26/22
- Travelzoo expects substantially higher revenue and profitability in Q4
- 08/01/22
- Travelzoo trading resumes
- 08/01/22
- Travelzoo trading halted, volatility trading pause
- 12/14/22
- Twitter shutting down newsletter platform Revue
- 12/12/22
- Twitter debuts Blue for Business, gold checkmarks for corporate entities
- 11/30/22
- Musk says Apple CEO never considered removing Twitter from App Store
- 12/16/22
- Trean Insurance to be acquired by Altaris Capital for $6.15 per share in cash
- 07/26/22
- Trean Insurance announces exclusive partnership with Beat Capital
- 11/10/22
- Steel Dynamics announces additional $1.5B share repurchase program
- 11/02/22
- Steel Dynamics selects Columbus, Mississippi, as location for aluminum mill
- 10/19/22
- Steel Dynamics says 'customer order entry activity continues to be healthy'
- 10/04/22
- Steel Dynamics completes acquisition of ROCA ACERO
- 11/28/22
- Sarepta announces FDA grants priority review for SRP-9001 BLA
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 09/29/22
- Sarepta submits BLA to FDA for accelerated approval of SRP-9001
- 09/14/22
- Sarepta prices $1B of convertible senior notes due 2027
- 12/16/22
- Planet Labs rises 10.2%
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 08/03/22
- New York Times sees FY22 CapEx approximately $55M
- 12/16/22
- Here's why Natera is jumping in afternoon trading
- 12/16/22
- ACMG publishes new guideline recommending NIPS for all pregnant individuals
- 12/09/22
- Natera: Published study highlights utility of Signatera test
- 12/06/22
- Natera publishes experience study in twin pregnancies in Prenatal Diagnosis
- 12/16/22
- Meta shutting down Cameo-like app Super
- 12/15/22
- Meta Platforms announces seven new solar projects in Georgia, Tennessee
- 12/13/22
- Rubio, Gallagher introduce bipartisan legislation to ban TikTok
- 12/13/22
- Instagram rolls out Notes for short messaging
- $51.85 /
+28.8 (+124.95%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/15/22
- IMV Inc. to present initial patient data from VITALIZE trial
- 12/13/22
- IMV begins trading on the TSX and Nasdaq post-reverse stock split
- 12/07/22
- IMV Inc. shareholders approve reverse stock split at 88%
- 09/30/22
- IMV Inc. provides update on VITALIZE study
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/29/22
- Stack Capital invests $8M in Locus Robotics
- 11/22/22
- Goldman Sachs Asset Management to pay $4M penalty to settle SEC charges
- 11/16/22
- Goldman Sachs exec sells $3.86M in common stock
- 12/15/22
- Guardant Health reports 'positive' results from ECLIPSE study
- 12/08/22
- Guardant Health announces collaboration with AstraZeneca
- 08/31/22
- Guardant Health expands strategic collaboration with Merck KGaA in oncology
- 08/12/22
- Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx
- 12/16/22
- Arvinas appoints Everett Cunningham to board of directors
- 12/09/22
- Exact Sciences announces initial clinical validation data for POLAR
- 11/02/22
- Cathie Wood's ARK Investment bought 106.8K shares of Exact Sciences today
- 11/01/22
- Cathie Wood's ARK Investment bought 104K shares of Exact Sciences today
- 12/16/22
- Darden reports Q2 blended same-restaurant sales increase of 7.3%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 06/23/22
- Darden announces new $1B share repurchase program
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 12/09/22
- Disney+ Basic not currently available on Roku devices
- 12/08/22
- Disney announces ad-supported Disney+ plan available in the U.S.
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 12/14/22
- Centene announces new leadership appointments
- 12/05/22
- Centene completes divestiture of Magellan Rx to Prime Therapeutics
- 11/17/22
- Centene signs agreement to sell Magellan Specialty Health to Evolent Health
- 12/13/22
- Avaya appoints RingCentral board nominee to board, says committed to partnership
- 11/07/22
- Avaya names Becky Roof named interim CFO amid Kieran McGrath retirement
- 09/06/22
- Avaya sees $23M-$26M in pre-tax charges from workforce reduction
- 08/16/22
- Avaya receives NYSE notice regarding late 10-Q fifling
- 07/17/22
- Fly Intel: Top five weekend stock stories
- 12/15/22
- Agilysys announces agreement with Marriott to deploy PMS software
- 12/15/22
- Adobe says regulatory process for Figma acquisition is proceeding as expected
- 12/06/22
- Adobe Stock to sell AI-generated images
- 11/27/22
- Fly Intel: Top five weekend stock stories
- 10/26/22
- Adobe director sells $5.4M in common stock
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 12/13/22
- American Airlines names Devon May Chief Financial Officer
- 12/09/22
- JetBlue, American Airlines add destinations taking off from New York, Boston
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- American Airlines: Pilot issues to take 2-3 years to work out
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 12/13/22 BofA
- Centene downgraded to Underperform from Neutral at BofA
- 11/23/22 Morgan Stanley
- CVS Health assumed with an Overweight at Morgan Stanley
- 11/18/22 Cowen
- Evolent Health price target raised to $57 from $52 at Cowen
- 10/24/22 DA Davidson
- Winnebago price target lowered to $54 from $60 at DA Davidson
- 10/03/22 MKM Partners
- Winnebago price target lowered to $56 from $67 at MKM Partners
- 08/09/22 MKM Partners
- Winnebago cut to Neutral at MKM Partners on valuation, worsened conditions
- 08/09/22 MKM Partners
- Winnebago downgraded to Neutral from Buy at MKM Partners
- 12/16/22 Stifel
- Adobe price target raised to $400 from $375 at Stifel
- 12/16/22 Evercore ISI
- Adobe price target raised to $425 from $350 at Evercore ISI
- 12/16/22 Morgan Stanley
- Adobe price target raised to $382 from $337 at Morgan Stanley
- 12/16/22 BMO Capital
- Adobe price target raised to $390 from $332 at BMO Capital
- $264.42 /
-16.66 (-5.93%) - 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 12/14/22 Wedbush
- Darden upgraded to Outperform from Neutral at Wedbush
- 12/12/22 RBC Capital
- Darden price target raised to $155 from $144 at RBC Capital
- 12/09/22 KeyBanc
- Darden price target raised to $160 from $150 at KeyBanc
- 12/09/22 Barclays
- Darden price target raised to $146 from $136 at Barclays
- $51.85 /
+28.8 (+124.95%) - 12/16/22 Wells Fargo
- Maxar Technologies downgraded to Equal Weight from Overweight at Wells Fargo
- 12/16/22 Canaccord
- Maxar Technologies downgraded to Hold from Buy at Canaccord
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line at Evercore ISI after reserve review
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line from Outperform at Evercore ISI
- 03/29/22 JPMorgan
- Trean Insurance downgraded to Neutral from Overweight at JPMorgan
- 01/14/22 JMP Securities
- Trean Insurance price target lowered to $14 from $18 at JMP Securities
- 12/16/22 JPMorgan
- Meta Platforms upgraded to Overweight from Neutral at JPMorgan
- 11/15/22 Morgan Stanley
- Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
- 11/10/22 Canaccord
- Meta Platforms price target lowered to $170 from $200 at Canaccord
- 11/09/22 Itau BBA
- Meta Platforms price target raised to $120 from $102 at Itau BBA
- 12/16/22 BTIG
- BTIG upgrades Agilysys to Buy on 'game-changing contract win'
- 12/16/22 BTIG
- Agilysys upgraded to Buy from Neutral at BTIG
- 12/15/22 Craig-Hallum
- Agilysys price target raised to $80 from $65 at Craig-Hallum
- 10/26/22 Craig-Hallum
- Craig-Hallum upgrades Agilysys to Buy, raises price target to $65
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- 12/16/22 JPMorgan
- AvalonBay downgraded to Underweight from Neutral at JPMorgan
- 12/08/22 Goldman Sachs
- AvalonBay downgraded to Neutral from Buy at Goldman Sachs
- 12/07/22 KeyBanc
- AvalonBay price target lowered to $193 from $237 at KeyBanc
- 12/02/22 Morgan Stanley
- AvalonBay downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/12/22 Morgan Stanley
- Disney price target lowered to $115 from $125 at Morgan Stanley
- 11/30/22 Atlantic Equities
- Atlantic Equities sees 'no easy fix' for Iger at Disney
- 11/22/22 Tigress Financial
- Disney price target lowered to $177 from $229 at Tigress Financial
- 11/21/22 JPMorgan
- JPMorgan 'reluctant to recommend chasing' Disney shares on rally
- 08/10/22 Goldman Sachs
- Goldman Sachs suspends rating on Avaya amid investigations
- 08/10/22 Barclays
- Avaya price target lowered to 50c from $2 at Barclays
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 12/14/22 Wells Fargo
- Goldman Sachs price target raised to $400 from $380 at Wells Fargo
- 10/19/22 BMO Capital
- Goldman Sachs price target lowered to $469 from $470 at BMO Capital
- 10/19/22 Barclays
- Goldman Sachs price target lowered to $410 from $450 at Barclays
- 10/19/22 Oppenheimer
- Goldman Sachs price target lowered to $477 from $483 at Oppenheimer
- 12/16/22 Goldman Sachs
- American Airlines resumed with a Neutral at Goldman Sachs
- 10/17/22 Citi
- American Airlines price target lowered to $15 from $16 at Citi
- 10/12/22 Barclays
- American Airlines price target lowered to $14 from $17 at Barclays
- 10/06/22 BofA
- American Airlines price target lowered to $7 from $8 at BofA
- 11/23/22 Morgan Stanley
- Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
- 10/31/22 Gordon Haskett
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/21/22 Wedbush
- Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
- 10/18/22 Gordon Haskett
- Bilson sees Tesla share sale coming with Musk $8B short for Twitter
WBD Warner Bros. Discovery - 12/07/22 BofA
- Warner Bros. Discovery the 'best value in media,' says BofA
- 11/14/22 Spin-Off Research
- Warner Bros. Discovery downgraded to Hold from Buy at Spin-Off Research
- 11/10/22 Citi
- Warner Bros. Discovery price target lowered to $18 from $21 at Citi
- 11/08/22 Deutsche Bank
- Warner Bros. Discovery price target lowered to $35 from $48 at Deutsche Bank
- 12/16/22 Goldman Sachs
- Goldman says Guardant selloff, Exact Science rally an overreaction
- 12/16/22 Jefferies
- Guardant data missing expectations removes overhang on Exact, says Jefferies
- 11/14/22 Piper Sandler
- Exact Sciences price target raised to $50 from $40 at Piper Sandler
- 11/07/22 Raymond James
- Exact Sciences price target lowered to $60 from $70 at Raymond James
- 12/16/22 BofA
- Guardant Health price target raised to $70 from $65 at BofA
- 12/16/22 Cowen
- Guardant Health price target lowered to $70 from $83 at Cowen
- 12/16/22 Morgan Stanley
- Guardant's 'optical miss' presents 'compelling' entry point, says Morgan Stanley
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 12/16/22 Piper Sandler
- ACMG recommends 22Q screening, Natera runs micro deletion, says Piper Sandler
- 12/16/22 Stephens
- ACMG updated recommendations a positive for Natera, Myriad, says Stephens
- 11/14/22 Credit Suisse
- Natera price target lowered to $55 from $70 at Credit Suisse
- 11/10/22 Raymond James
- CareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James
- 10/06/22 Goldman Sachs
- U.S. Steel price target lowered to $18 from $21 at Goldman Sachs
- 10/04/22 Morgan Stanley
- U.S. Steel said to be idling more capacity, says Morgan Stanley
- 09/16/22 Credit Suisse
- U.S. Steel price target lowered to $37 from $44 at Credit Suisse
- 07/27/22 GLJ Research
- Cleveland-Cliffs downgraded to Sell from Buy at GLJ Research
- 11/28/22 Barrington
- Travelzoo downgraded to Market Perform from Outperform at Barrington
- 08/08/22 Ascendiant
- Travelzoo upgraded to Buy from Hold at Ascendiant
- 07/29/22 Barrington
- Travelzoo price target lowered to $10 from $12 at Barrington
- 03/18/22 Ascendiant
- Travelzoo downgraded to Hold from Buy at Ascendiant
- 12/05/22 UBS
- Steel Dynamics downgraded to Neutral from Buy at UBS
- 11/14/22 BMO Capital
- Steel Dynamics price target raised to $100 from $89 at BMO Capital
- 10/21/22 BMO Capital
- Steel Dynamics price target raised to $89 from $77 at BMO Capital
- 10/06/22 Goldman Sachs
- Steel Dynamics upgraded to Buy from Neutral at Goldman Sachs
- 12/16/22 UBS
- Sarepta upgraded to Buy at UBS ahead of 'highly likely' SRP-9001 approval
- 12/16/22 UBS
- Sarepta upgraded to Buy from Neutral at UBS
- 12/13/22 Cantor Fitzgerald
- Sarepta price target raised to $174 from $150 at Cantor Fitzgerald
- 11/28/22 Barclays
- Catalent had 483s cleared, removing overhang, says Barclays
- 12/15/22
- U.S. Steel sees Q4 adjusted EPS 58c-63c, consensus 43c
- 10/27/22
- U.S. Steel reports Q3 adjusted EPS $1.95, consensus $1.93
- 09/15/22
- U.S. Steel sees Q3 adjusted EPS $1.90-$1.95, consensus $1.90
- 07/28/22
- U.S. Steel reports Q2 EPS $3.86, consensus $3.87
- 12/16/22
- Winnebago reports Q1 adjusted EPS $2.07, consensus $1.78
- 10/19/22
- Winnebago reports Q4 adjusted EPS $3.02, consensus $2.76
- 06/22/22
- Winnebago reports Q3 adjusted EPS $4.13, consensus $2.96
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 12/16/22
- Travelzoo sees Q4 revenue $18.5M, consensus $17.6M
- 10/26/22
- Travelzoo reports Q3 EPS 6c, consensus 11c
- 07/27/22
- Travelzoo sees Q3 revenue higher year-over-year, consensus $21.36M
- 07/27/22
- Travelzoo reports Q2 EPS 8c, consensus 19c
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Trean Insurance sees Q4 loss ration consistent with Q3
- 11/02/22
- Trean Insurance raises FY22 revenue outlook to $278M-$383M from $255M-$265M
- 11/02/22
- Trean Insurance reports Q3 adjusted EPS 11c, consensus 9c
- 08/03/22
- Trean Insurance reports Q2 EPS 11c, consensus 7c
- 12/15/22
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- 10/19/22
- Steel Dynamics reports Q3 adjusted EPS $5.46, consensus $5.09
- 09/15/22
- Steel Dynamics sees Q3 adjusted EPS $5.33-$5.37, consensus $4.90
- 07/20/22
- Steel Dynamics reports Q2 adjusted EPS $6.73, consensus $6.05
- 11/02/22
- Sarepta reports Q EPS (80c), consensus (1.43)
- 08/02/22
- Sarepta reports Q2 EPS ($1.18), consensus ($1.18)
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 08/03/22
- New York Times reports Q2 adjusted EPS 24c, consensus 19c
- 11/08/22
- Natera raises FY22 revenue view to $810M-$830M from $805M-$825M
- 11/08/22
- Natera reports Q3 EPS ($1.25), consensus ($1.44)
- 08/04/22
- Natera raises FY22 revenue view to $805M-$825M from $790M-$810M
- 08/04/22
- Natera reports Q2 EPS ($1.50), consensus ($1.50)
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 10/26/22
- Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
- 10/26/22
- Meta Platforms reports Q3 EPS $1.64, consensus $1.89
- 10/26/22
- Notable companies reporting after market close
- $51.85 /
+28.8 (+124.95%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 11/10/22
- IMV Inc. reports Q3 EPS (11c), consensus (15c)
- 08/11/22
- IMV Inc. reports Q2 EPS (12c), consensus (12c)
- 10/18/22
- Goldman Sachs reports Q3 EPS $8.25, consensus $7.69
- 10/17/22
- Notable companies reporting before tomorrow's open
- 07/18/22
- Goldman Sachs reports Q2 EPS $7.73, consensus $7.25
- 11/03/22
- Guardant Health cuts FY22 revenue view to $440M-$460M, consensus $461.29M
- 11/03/22
- Guardant Health reports Q3 adjusted EPS ($1.18), consensus ($1.26)
- 08/04/22
- Guardant Health backs FY22 revenue $460M-$470M, consensus $465.29M
- 08/04/22
- Guardant Health reports Q2 adjusted EPS ($1.00), consensus ($1.21)
- 11/03/22
- Exact Sciences raises FY22 revenue view to $2.025B-$2.042B, consensus $2.01B
- 11/03/22
- Exact Sciences reports Q3 EPS (84c), consensus ($1.08)
- 08/02/22
- Exact Sciences lowers FY22 revenue view to $1.980B-$2.022B from $1.985B-$2.032B
- 08/02/22
- Exact Sciences reports Q2 EPS (94c), consensus ($1.07)
- 12/16/22
- Darden revises FY23 EPS view to $7.60-$8.00 from $7.40-$8.00, consensus $7.71
- 12/16/22
- Darden reports Q2 EPS $1.52, consensus $1.43
- 12/15/22
- Notable companies reporting before tomorrow's open
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 11/08/22
- Notable companies reporting after market close
- 08/10/22
- Disney reports Q3 EPS ex-items $1.09, consensus $1.00
- 12/16/22
- Centene backs FY22 adjusted EPS view $5.65-$5.75, consensus $5.74
- 12/16/22
- Centene sees FY23 adjusted EPS $6.25-$6.40, consensus $6.34
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- 10/25/22
- Centene raises FY22 adjusted EPS view to $5.65-$5.75 from $5.60-$5.70
- 08/09/22
- Avaya sees Q3 non-GAAP EPS 24c, consensus 5c
- 07/28/22
- Avaya sees Q3 revenue $575M-$580M, below previous guidance of $685M-$700M
- 11/03/22
- AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96
- 11/03/22
- AvalonBay sees Q4 core FFO $2.55-$2.65
- 11/03/22
- AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53
- 07/27/22
- AvalonBay sees FY22 core FFO $9.76-$9.96, consensus $9.62
- 10/25/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $194.05M
- 10/25/22
- Agilysys reports Q1 adjusted EPS 24c, consensus 18c
- 07/26/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $192.84M
- 07/26/22
- Agilysys reports Q1 adjusted EPS 21c, consensus 18c
- 12/15/22
- Adobe backs FY23 adjusted EPS view $15.15-$15.45, consensus $15.25
- 12/15/22
- Adobe sees Q1 adjusted EPS $3.65-$3.70, consensus $3.64
- 12/15/22
- Adobe reports Q4 adjusted EPS $3.60, consensus $3.50
- 12/15/22
- Notable companies reporting after market close
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 10/20/22
- American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c
- 10/20/22
- American Airlines reports Q3 EPS 69c, consensus 56c
- 10/19/22
- Notable companies reporting before tomorrow's open
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/15/22
- Trane commits to low-carbon steel purchases from Nucor, U.S. Steel
- 11/08/22
- U.S. Steel announces tentative agreement with United Steelworkers
- 09/15/22
- U.S. Steel slips after Q3 earnings guidance
- 08/16/22
- U.S. Steel, Equinor and Shell enter a cooperation agreement for clean energy hub
- 12/16/22
- Winnebago CEO says 2023 'critically important' for maintaining momentum
- 11/15/22
- Winnebago presents 2025 targets at investor day
- 11/15/22
- Winnebago to establish dedicated research, development facility
- 10/19/22
- Winnebago falls -10.4%
WBD Warner Bros. Discovery - 12/14/22
- Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023
- 12/06/22
- Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S.
- 11/14/22
- U.S. game content spending grew 2% y/y in October, says NPD
- 11/10/22
- Sony says 'Modern Warfare II' tops PS5 digital downloads in October
- 11/25/22
- Travelzoo to sell 3.41M shares to largest shareholder, Azzurro Capital
- 10/26/22
- Travelzoo expects substantially higher revenue and profitability in Q4
- 08/01/22
- Travelzoo trading resumes
- 08/01/22
- Travelzoo trading halted, volatility trading pause
- 12/14/22
- Twitter shutting down newsletter platform Revue
- 12/12/22
- Twitter debuts Blue for Business, gold checkmarks for corporate entities
- 11/30/22
- Musk says Apple CEO never considered removing Twitter from App Store
- 12/16/22
- Trean Insurance to be acquired by Altaris Capital for $6.15 per share in cash
- 07/26/22
- Trean Insurance announces exclusive partnership with Beat Capital
- 11/10/22
- Steel Dynamics announces additional $1.5B share repurchase program
- 11/02/22
- Steel Dynamics selects Columbus, Mississippi, as location for aluminum mill
- 10/19/22
- Steel Dynamics says 'customer order entry activity continues to be healthy'
- 10/04/22
- Steel Dynamics completes acquisition of ROCA ACERO
- 11/28/22
- Sarepta announces FDA grants priority review for SRP-9001 BLA
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 09/29/22
- Sarepta submits BLA to FDA for accelerated approval of SRP-9001
- 09/14/22
- Sarepta prices $1B of convertible senior notes due 2027
- 12/16/22
- Planet Labs rises 10.2%
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 08/03/22
- New York Times sees FY22 CapEx approximately $55M
- 12/16/22
- Meta shutting down Cameo-like app Super
- 12/15/22
- Meta Platforms announces seven new solar projects in Georgia, Tennessee
- 12/13/22
- Rubio, Gallagher introduce bipartisan legislation to ban TikTok
- 12/13/22
- Instagram rolls out Notes for short messaging
- $51.43 /
+28.38 (+123.12%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/15/22
- IMV Inc. to present initial patient data from VITALIZE trial
- 12/13/22
- IMV begins trading on the TSX and Nasdaq post-reverse stock split
- 12/07/22
- IMV Inc. shareholders approve reverse stock split at 88%
- 09/30/22
- IMV Inc. provides update on VITALIZE study
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/29/22
- Stack Capital invests $8M in Locus Robotics
- 11/22/22
- Goldman Sachs Asset Management to pay $4M penalty to settle SEC charges
- 11/16/22
- Goldman Sachs exec sells $3.86M in common stock
- $28.41 /
-12.84 (-31.13%) - 12/15/22
- Guardant Health reports 'positive' results from ECLIPSE study
- 12/08/22
- Guardant Health announces collaboration with AstraZeneca
- 08/31/22
- Guardant Health expands strategic collaboration with Merck KGaA in oncology
- 08/12/22
- Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx
- 07/19/22
- Gencor Industries transfers common stock listing to NYSE American
- 12/16/22
- Arvinas appoints Everett Cunningham to board of directors
- 12/09/22
- Exact Sciences announces initial clinical validation data for POLAR
- 11/02/22
- Cathie Wood's ARK Investment bought 106.8K shares of Exact Sciences today
- 11/01/22
- Cathie Wood's ARK Investment bought 104K shares of Exact Sciences today
- 12/16/22
- Darden reports Q2 blended same-restaurant sales increase of 7.3%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 06/23/22
- Darden announces new $1B share repurchase program
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 12/14/22
- Centene announces new leadership appointments
- 12/05/22
- Centene completes divestiture of Magellan Rx to Prime Therapeutics
- 11/17/22
- Centene signs agreement to sell Magellan Specialty Health to Evolent Health
- 12/13/22
- Avaya appoints RingCentral board nominee to board, says committed to partnership
- 11/07/22
- Avaya names Becky Roof named interim CFO amid Kieran McGrath retirement
- 09/06/22
- Avaya sees $23M-$26M in pre-tax charges from workforce reduction
- 08/16/22
- Avaya receives NYSE notice regarding late 10-Q fifling
- 07/17/22
- Fly Intel: Top five weekend stock stories
- 12/15/22
- Apollo funds provide $200M to WEC Energy renewable porfolio
- 11/29/22
- Atlas Air Worldwide shareholders approve of proposed acquisition by Apollo
- 11/29/22
- Apollo Global appoints Wooden as Partner, Chief Public Pension Strategist
- 11/28/22
- Taboola, Yahoo enter 30-year commercial agreement
- 12/15/22
- Agilysys announces agreement with Marriott to deploy PMS software
- $339.25 /
+10.36 (+3.15%) - 12/15/22
- Adobe says regulatory process for Figma acquisition is proceeding as expected
- 12/06/22
- Adobe Stock to sell AI-generated images
- 11/27/22
- Fly Intel: Top five weekend stock stories
- 10/26/22
- Adobe director sells $5.4M in common stock
- $264.91 /
-16.17 (-5.75%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 12/13/22
- American Airlines names Devon May Chief Financial Officer
- 12/09/22
- JetBlue, American Airlines add destinations taking off from New York, Boston
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- American Airlines: Pilot issues to take 2-3 years to work out
- $339.25 /
+10.36 (+3.15%) - 12/16/22 Stifel
- Adobe price target raised to $400 from $375 at Stifel
- 12/16/22 Evercore ISI
- Adobe price target raised to $425 from $350 at Evercore ISI
- 12/16/22 Morgan Stanley
- Adobe price target raised to $382 from $337 at Morgan Stanley
- 12/16/22 BMO Capital
- Adobe price target raised to $390 from $332 at BMO Capital
- $264.91 /
-16.17 (-5.75%) - 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 12/14/22 Wedbush
- Darden upgraded to Outperform from Neutral at Wedbush
- 12/12/22 RBC Capital
- Darden price target raised to $155 from $144 at RBC Capital
- 12/09/22 KeyBanc
- Darden price target raised to $160 from $150 at KeyBanc
- 12/09/22 Barclays
- Darden price target raised to $146 from $136 at Barclays
- $51.43 /
+28.38 (+123.12%) - 12/16/22 Canaccord
- Maxar Technologies downgraded to Hold from Buy at Canaccord
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 11/07/22 BMO Capital
- Maxar Technologies price target lowered to $27 from $32 at BMO Capital
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line at Evercore ISI after reserve review
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line from Outperform at Evercore ISI
- 03/29/22 JPMorgan
- Trean Insurance downgraded to Neutral from Overweight at JPMorgan
- 01/14/22 JMP Securities
- Trean Insurance price target lowered to $14 from $18 at JMP Securities
- 12/16/22 JPMorgan
- Meta Platforms upgraded to Overweight from Neutral at JPMorgan
- 11/15/22 Morgan Stanley
- Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
- 11/10/22 Canaccord
- Meta Platforms price target lowered to $170 from $200 at Canaccord
- 11/09/22 Itau BBA
- Meta Platforms price target raised to $120 from $102 at Itau BBA
- 12/16/22 BTIG
- BTIG upgrades Agilysys to Buy on 'game-changing contract win'
- 12/16/22 BTIG
- Agilysys upgraded to Buy from Neutral at BTIG
- 12/15/22 Craig-Hallum
- Agilysys price target raised to $80 from $65 at Craig-Hallum
- 10/26/22 Craig-Hallum
- Craig-Hallum upgrades Agilysys to Buy, raises price target to $65
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- 12/16/22 JPMorgan
- AvalonBay downgraded to Underweight from Neutral at JPMorgan
- 12/08/22 Goldman Sachs
- AvalonBay downgraded to Neutral from Buy at Goldman Sachs
- 12/07/22 KeyBanc
- AvalonBay price target lowered to $193 from $237 at KeyBanc
- 12/02/22 Morgan Stanley
- AvalonBay downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/10/22 Goldman Sachs
- Goldman Sachs suspends rating on Avaya amid investigations
- 08/10/22 Barclays
- Avaya price target lowered to 50c from $2 at Barclays
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 12/14/22 Wells Fargo
- Goldman Sachs price target raised to $400 from $380 at Wells Fargo
- 10/19/22 BMO Capital
- Goldman Sachs price target lowered to $469 from $470 at BMO Capital
- 10/19/22 Barclays
- Goldman Sachs price target lowered to $410 from $450 at Barclays
- 10/19/22 Oppenheimer
- Goldman Sachs price target lowered to $477 from $483 at Oppenheimer
- 12/16/22 Goldman Sachs
- American Airlines resumed with a Neutral at Goldman Sachs
- 10/17/22 Citi
- American Airlines price target lowered to $15 from $16 at Citi
- 10/12/22 Barclays
- American Airlines price target lowered to $14 from $17 at Barclays
- 10/06/22 BofA
- American Airlines price target lowered to $7 from $8 at BofA
- 11/23/22 Morgan Stanley
- Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
- 10/31/22 Gordon Haskett
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/21/22 Wedbush
- Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
- 10/18/22 Gordon Haskett
- Bilson sees Tesla share sale coming with Musk $8B short for Twitter
WBD Warner Bros. Discovery - 12/07/22 BofA
- Warner Bros. Discovery the 'best value in media,' says BofA
- 11/14/22 Spin-Off Research
- Warner Bros. Discovery downgraded to Hold from Buy at Spin-Off Research
- 11/10/22 Citi
- Warner Bros. Discovery price target lowered to $18 from $21 at Citi
- 11/08/22 Deutsche Bank
- Warner Bros. Discovery price target lowered to $35 from $48 at Deutsche Bank
- 11/15/22 Deutsche Bank
- Apollo Global price target raised to $83 from $81 at Deutsche Bank
- 11/03/22 Barclays
- Apollo Global price target raised to $73 from $65 at Barclays
- 11/03/22 Deutsche Bank
- Apollo Global price target raised to $81 from $78 at Deutsche Bank
- 10/19/22 UBS
- Apollo Global price target lowered to $55 from $60 at UBS
- 11/23/22 Morgan Stanley
- EQT AB resumed with an Equal Weight at Morgan Stanley
- 11/01/22 Goldman Sachs
- EQT AB reinstated with a Buy at Goldman Sachs
- 10/27/22 Credit Suisse
- EQT AB initiated with an Underperform at Credit Suisse
- 10/19/22 Societe Generale
- EQT AB price target lowered to SEK 230 from SEK 250 at Societe Generale
- 12/16/22 Goldman Sachs
- Goldman says Guardant selloff, Exact Science rally an overreaction
- 12/16/22 Jefferies
- Guardant data missing expectations removes overhang on Exact, says Jefferies
- 11/14/22 Piper Sandler
- Exact Sciences price target raised to $50 from $40 at Piper Sandler
- 11/07/22 Raymond James
- Exact Sciences price target lowered to $60 from $70 at Raymond James
- $28.41 /
-12.84 (-31.13%) - 12/16/22 BofA
- Guardant Health price target raised to $70 from $65 at BofA
- 12/16/22 Cowen
- Guardant Health price target lowered to $70 from $83 at Cowen
- 12/16/22 Morgan Stanley
- Guardant's 'optical miss' presents 'compelling' entry point, says Morgan Stanley
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 10/06/22 Goldman Sachs
- U.S. Steel price target lowered to $18 from $21 at Goldman Sachs
- 10/04/22 Morgan Stanley
- U.S. Steel said to be idling more capacity, says Morgan Stanley
- 09/16/22 Credit Suisse
- U.S. Steel price target lowered to $37 from $44 at Credit Suisse
- 07/27/22 GLJ Research
- Cleveland-Cliffs downgraded to Sell from Buy at GLJ Research
- 11/28/22 Barrington
- Travelzoo downgraded to Market Perform from Outperform at Barrington
- 08/08/22 Ascendiant
- Travelzoo upgraded to Buy from Hold at Ascendiant
- 07/29/22 Barrington
- Travelzoo price target lowered to $10 from $12 at Barrington
- 03/18/22 Ascendiant
- Travelzoo downgraded to Hold from Buy at Ascendiant
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 12/13/22 BofA
- Centene downgraded to Underperform from Neutral at BofA
- 11/23/22 Morgan Stanley
- CVS Health assumed with an Overweight at Morgan Stanley
- 11/18/22 Cowen
- Evolent Health price target raised to $57 from $52 at Cowen
- 10/24/22 DA Davidson
- Winnebago price target lowered to $54 from $60 at DA Davidson
- 10/03/22 MKM Partners
- Winnebago price target lowered to $56 from $67 at MKM Partners
- 08/09/22 MKM Partners
- Winnebago cut to Neutral at MKM Partners on valuation, worsened conditions
- 08/09/22 MKM Partners
- Winnebago downgraded to Neutral from Buy at MKM Partners
- 12/05/22 UBS
- Steel Dynamics downgraded to Neutral from Buy at UBS
- 11/14/22 BMO Capital
- Steel Dynamics price target raised to $100 from $89 at BMO Capital
- 10/21/22 BMO Capital
- Steel Dynamics price target raised to $89 from $77 at BMO Capital
- 10/06/22 Goldman Sachs
- Steel Dynamics upgraded to Buy from Neutral at Goldman Sachs
- 12/16/22 UBS
- Sarepta upgraded to Buy at UBS ahead of 'highly likely' SRP-9001 approval
- 12/16/22 UBS
- Sarepta upgraded to Buy from Neutral at UBS
- 12/13/22 Cantor Fitzgerald
- Sarepta price target raised to $174 from $150 at Cantor Fitzgerald
- 11/28/22 Barclays
- Catalent had 483s cleared, removing overhang, says Barclays
- 12/15/22
- U.S. Steel sees Q4 adjusted EPS 58c-63c, consensus 43c
- 10/27/22
- U.S. Steel reports Q3 adjusted EPS $1.95, consensus $1.93
- 09/15/22
- U.S. Steel sees Q3 adjusted EPS $1.90-$1.95, consensus $1.90
- 07/28/22
- U.S. Steel reports Q2 EPS $3.86, consensus $3.87
- 12/16/22
- Winnebago reports Q1 adjusted EPS $2.07, consensus $1.78
- 10/19/22
- Winnebago reports Q4 adjusted EPS $3.02, consensus $2.76
- 06/22/22
- Winnebago reports Q3 adjusted EPS $4.13, consensus $2.96
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 12/16/22
- Travelzoo sees Q4 revenue $18.5M, consensus $17.6M
- 10/26/22
- Travelzoo reports Q3 EPS 6c, consensus 11c
- 07/27/22
- Travelzoo sees Q3 revenue higher year-over-year, consensus $21.36M
- 07/27/22
- Travelzoo reports Q2 EPS 8c, consensus 19c
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Trean Insurance sees Q4 loss ration consistent with Q3
- 11/02/22
- Trean Insurance raises FY22 revenue outlook to $278M-$383M from $255M-$265M
- 11/02/22
- Trean Insurance reports Q3 adjusted EPS 11c, consensus 9c
- 08/03/22
- Trean Insurance reports Q2 EPS 11c, consensus 7c
- 12/15/22
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- 10/19/22
- Steel Dynamics reports Q3 adjusted EPS $5.46, consensus $5.09
- 09/15/22
- Steel Dynamics sees Q3 adjusted EPS $5.33-$5.37, consensus $4.90
- 07/20/22
- Steel Dynamics reports Q2 adjusted EPS $6.73, consensus $6.05
- 11/02/22
- Sarepta reports Q EPS (80c), consensus (1.43)
- 08/02/22
- Sarepta reports Q2 EPS ($1.18), consensus ($1.18)
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 08/03/22
- New York Times reports Q2 adjusted EPS 24c, consensus 19c
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 10/26/22
- Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
- 10/26/22
- Meta Platforms reports Q3 EPS $1.64, consensus $1.89
- 10/26/22
- Notable companies reporting after market close
- $51.43 /
+28.38 (+123.12%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 11/10/22
- IMV Inc. reports Q3 EPS (11c), consensus (15c)
- 08/11/22
- IMV Inc. reports Q2 EPS (12c), consensus (12c)
- 10/18/22
- Goldman Sachs reports Q3 EPS $8.25, consensus $7.69
- 10/17/22
- Notable companies reporting before tomorrow's open
- 07/18/22
- Goldman Sachs reports Q2 EPS $7.73, consensus $7.25
- $28.41 /
-12.84 (-31.13%) - 11/03/22
- Guardant Health cuts FY22 revenue view to $440M-$460M, consensus $461.29M
- 11/03/22
- Guardant Health reports Q3 adjusted EPS ($1.18), consensus ($1.26)
- 08/04/22
- Guardant Health backs FY22 revenue $460M-$470M, consensus $465.29M
- 08/04/22
- Guardant Health reports Q2 adjusted EPS ($1.00), consensus ($1.21)
- 12/16/22
- Gencor Industries reports 2022 EPS (3c) vs. 39c last year
- 08/12/22
- Gencor Industries reports Q3 EPS (7c) vs. 16c last year
- 11/03/22
- Exact Sciences raises FY22 revenue view to $2.025B-$2.042B, consensus $2.01B
- 11/03/22
- Exact Sciences reports Q3 EPS (84c), consensus ($1.08)
- 08/02/22
- Exact Sciences lowers FY22 revenue view to $1.980B-$2.022B from $1.985B-$2.032B
- 08/02/22
- Exact Sciences reports Q2 EPS (94c), consensus ($1.07)
- 12/16/22
- Darden revises FY23 EPS view to $7.60-$8.00 from $7.40-$8.00, consensus $7.71
- 12/16/22
- Darden reports Q2 EPS $1.52, consensus $1.43
- 12/15/22
- Notable companies reporting before tomorrow's open
- 12/16/22
- Centene backs FY22 adjusted EPS view $5.65-$5.75, consensus $5.74
- 12/16/22
- Centene sees FY23 adjusted EPS $6.25-$6.40, consensus $6.34
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- 10/25/22
- Centene raises FY22 adjusted EPS view to $5.65-$5.75 from $5.60-$5.70
- 08/09/22
- Avaya sees Q3 non-GAAP EPS 24c, consensus 5c
- 07/28/22
- Avaya sees Q3 revenue $575M-$580M, below previous guidance of $685M-$700M
- 11/03/22
- AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96
- 11/03/22
- AvalonBay sees Q4 core FFO $2.55-$2.65
- 11/03/22
- AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53
- 07/27/22
- AvalonBay sees FY22 core FFO $9.76-$9.96, consensus $9.62
- 11/02/22
- Apollo Global reports Q3 EPS ($1.52) vs. $1.01 last year
- 11/01/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Apollo Global reports Q2 adjusted EPS 94c, consensus $1.02
- 10/25/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $194.05M
- 10/25/22
- Agilysys reports Q1 adjusted EPS 24c, consensus 18c
- 07/26/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $192.84M
- 07/26/22
- Agilysys reports Q1 adjusted EPS 21c, consensus 18c
- $339.25 /
+10.36 (+3.15%) - 12/15/22
- Adobe backs FY23 adjusted EPS view $15.15-$15.45, consensus $15.25
- 12/15/22
- Adobe sees Q1 adjusted EPS $3.65-$3.70, consensus $3.64
- 12/15/22
- Adobe reports Q4 adjusted EPS $3.60, consensus $3.50
- 12/15/22
- Notable companies reporting after market close
- $264.91 /
-16.17 (-5.75%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 10/20/22
- American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c
- 10/20/22
- American Airlines reports Q3 EPS 69c, consensus 56c
- 10/19/22
- Notable companies reporting before tomorrow's open
|